Men’s Health Update

Higher Coffee Intake May Reduce Risk for Prostate Cancer

Publish Date January 15, 2021

Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies

Black Men Report More Regret Over Prostate Cancer Treatment Decisions

Publish Date January 14, 2021

Mistrust and concerns about masculinity are important factors that influence Black men’s experience during prostate cancer management.

Use of Commercial Genomic Testing for Prostate Cancer ‘Highly Variable’ in the United States

Publish Date January 13, 2021

Investigators evaluated a large sample of commercially insured patients with prostate cancer to assess use of tissue-based gene expression testing.

Early High-Titer Plasma Reduces Progression of COVID-19

Publish Date January 12, 2021

Early administration of high-titer convalescent plasma against SARS-CoV-2 reduces progression in mildly ill older adults

Overall Survival Data Added to Nubeqa Prescribing Information

Publish Date January 12, 2021

Nubeqa, an androgen receptor inhibitor, was approved for the treatment of patients with nmCRPC based on data from the placebo-controlled phase 3 ARAMIS trial.

Advanced, Fatal Prostate Cancer Linked to Diet

Publish Date January 12, 2021

Diets that promote hyperinsulinemia and inflammation increase the likelihood of advanced or fatal prostate cancer, a new study suggests.

Time to Say Goodbye to the DRE for Prostate Cancer Screening

Publish Date January 12, 2021

With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.

FDA: SARS-CoV-2 Mutations May Impact Molecular Tests

Publish Date January 11, 2021

The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.

Mediterranean Diet May Lower Prostate Cancer Progression Risk

Publish Date January 11, 2021

In a study of men on active surveillance for localized prostate cancer, each 1-unit increase in Mediterranean diet score, calculated based on patients’ baseline food frequency questionnaire information, was associated with a 12% decreased risk for Gleason grade group progression.

Testosterone Therapy May Reduce Diabetes Risk

Publish Date January 8, 2021

Additional safety data on testosterone therapy are needed before it can be used to prevent type 2 diabetes.